<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39362870</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2373-8057</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>NPJ Parkinson's disease</Title><ISOAbbreviation>NPJ Parkinsons Dis</ISOAbbreviation></Journal><ArticleTitle>Prospective study of bipolar disorder and neurodegenerative diseases.</ArticleTitle><Pagination><StartPage>184</StartPage><MedlinePgn>184</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">184</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41531-024-00794-z</ELocationID><Abstract><AbstractText>Bipolar disorder (BD) is linked to an increased risk of neurodegenerative diseases such as dementia and Parkinson disease (PD), yet several uncertainties still remain and the extent to which the associations could be explained by BD-related medications (antipsychotics, lithium, and antiepileptics) was unknown. This study included 501,233 UK Biobank participants (mean [standard deviation] age, 56.5 [8.10] years; 54.4% women), free of dementia and PD at baseline. After a median 13.8 year follow-up, 9422 cases of dementia and 3457 PD cases were identified. Participants with BD had a significantly higher risk of dementia (adjusted hazard ratio [HR] 2.52, 95% CI 2.00-3.19) and PD (adjusted HR 2.88, 95% CI 2.03-4.08). Findings suggest that up to two-thirds of the association of neurodegenerative diseases with BD may be mediated by BD-related medications. Further research is needed to confirm these findings and explore the underlying mechanisms.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Xinming</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0005-3121-8138</Identifier><AffiliationInfo><Affiliation>Department of Nutrition and Food Hygiene, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, 200030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Yaqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Food Hygiene, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, 200030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Hanyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Food Hygiene, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, 200030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Food Hygiene, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, 200030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dregan</LastName><ForeName>Alexandru</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7620-4902</Identifier><AffiliationInfo><Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Food Hygiene, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, 200030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Food Hygiene, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, 200030, China. geng_tt@fudan.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-2617-6509</Identifier><AffiliationInfo><Affiliation>Department of Nutrition and Food Hygiene, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, 200030, China. xiang_gao@fudan.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>NPJ Parkinsons Dis</MedlineTA><NlmUniqueID>101675390</NlmUniqueID><ISSNLinking>2373-8057</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39362870</ArticleId><ArticleId IdType="pmc">PMC11450157</ArticleId><ArticleId IdType="doi">10.1038/s41531-024-00794-z</ArticleId><ArticleId IdType="pii">10.1038/s41531-024-00794-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ashok, A. H. et al. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Mol. Psychiatry22, 666–679 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5401767</ArticleId><ArticleId IdType="pubmed">28289283</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong, M. J. &amp; Okun, M. S. Diagnosis and treatment of Parkinson disease: a review. JAMA J. Am. Med. Assoc.323, 548–560 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32044947</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobili, A. et al. Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease. Nat. Commun.8, 14727 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382255</ArticleId><ArticleId IdType="pubmed">28367951</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, T. et al. Emerging neuroimaging biomarkers across disease stage in Parkinson disease: a review. JAMA Neurol.78, 1262–1272 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9017381</ArticleId><ArticleId IdType="pubmed">34459865</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis, A. W., Thibault, D. P., Schmidt, P. N., Dorsey, E. R. &amp; Weintraub, D. Hospital care for mental health and substance abuse conditions in Parkinson’s disease. Mov. Disord.31, 1810–1819 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5321632</ArticleId><ArticleId IdType="pubmed">27943472</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrag, A. et al. Widening the spectrum of risk factors, comorbidities, and prodromal features of Parkinson disease. JAMA Neurol.80, 161–171 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9641600</ArticleId><ArticleId IdType="pubmed">36342675</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, M. H. et al. Bipolar disorder and risk of Parkinson disease: a nationwide longitudinal study. Neurology92, E2735–E2742 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31118242</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison, P. J. &amp; Luciano, S. Incidence of Parkinson’s disease, dementia, cerebrovascular disease and stroke in bipolar disorder compared to other psychiatric disorders: an electronic health records network study of 66 million people. Bipolar Disord.23, 454–462 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33075191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, H. L., Lin, H. C. &amp; Chen, Y. H. Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study. Ann. Epidemiol.24, 206–213 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24462274</ArticleId></ArticleIdList></Reference><Reference><Citation>Forty, L. et al. Comorbid medical illness in bipolar disorder. Br. J. Psychiatry205, 465–472 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4248234</ArticleId><ArticleId IdType="pubmed">25359927</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz, B. S. et al. History of bipolar disorder and the risk of dementia: a systematic review and meta-analysis. Am. J. Geriatr. Psychiatry25, 357–362 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5365367</ArticleId><ArticleId IdType="pubmed">28161155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessing, L. V. &amp; Andersen, P. K. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J. Neurol. Neurosurg. Psychiatry75, 1662–1666 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1738846</ArticleId><ArticleId IdType="pubmed">15548477</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva, J., Gonçalves-Pereira, M., Xavier, M. &amp; Mukaetova-Ladinska, E. B. Affective disorders and risk of developing dementia: systematic review. Br. J. Psychiatry202, 177–186 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23457181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilkens, R., Bruce, D., Duke, J., Spilsbury, K. &amp; Semmens, J. Severe psychiatric disorders in mid-kife and risk of dementia in late- life (Age 65–84 Years): a population based case-control study. Curr. Alzheimer Res.11, 681–693 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4153082</ArticleId><ArticleId IdType="pubmed">25115541</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida, O. P. et al. Risk of dementia and death in community-dwelling older men with bipolar disorder. Br. J. Psychiatry209, 121–126 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27482038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson, F. M. &amp; Kessing, L. V. Increased risk of developing stroke for patients with major affective disorder: a registry study. Eur. Arch. Psychiatry Clin. Neurosci.254, 387–391 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15538602</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma, R. B. &amp; Berg, D. Advances in markers of prodromal Parkinson disease. Nat. Rev. Neurol.12, 622–634 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27786242</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiba, M. et al. Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov. Disord.15, 669–677 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10928577</ArticleId></ArticleIdList></Reference><Reference><Citation>Faustino, P. R. et al. Risk of developing Parkinson disease in bipolar disorder. JAMA Neurol.77, 192 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802493</ArticleId><ArticleId IdType="pubmed">31609378</ArticleId></ArticleIdList></Reference><Reference><Citation>Belete, D. et al. Association between antiepileptic drugs and incident Parkinson disease. JAMA Neurol.80, 183–187 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9857018</ArticleId><ArticleId IdType="pubmed">36574240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobczak, S., Honig, A., van Duinen, M. A. &amp; Riedel, W. J. Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. Bipolar Disord.4, 347–356 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12519094</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrêa-Velloso, J. C. et al. Pathophysiology in the comorbidity of bipolar disorder and Alzheimer’s disease: pharmacological and stem cell approaches. Prog. Neuro Psychopharmacol. Biol. Psychiatry80, 34–53 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28476640</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga, S., Blauwendraat, C. &amp; Singleton, A. B. Assessment of genetic association between Parkinson disease and bipolar disorder. JAMA Neurol.77, 1034 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7215621</ArticleId><ArticleId IdType="pubmed">32391853</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub, D. et al. Association of antipsychotic use with mortality risk in patients with Parkinson disease. JAMA Neurol.73, 535–541 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5157923</ArticleId><ArticleId IdType="pubmed">26999262</ArticleId></ArticleIdList></Reference><Reference><Citation>Liperoti, R. et al. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents With dementia. J. Clin. Psychiatry70, 1340–1347 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3775351</ArticleId><ArticleId IdType="pubmed">19906339</ArticleId></ArticleIdList></Reference><Reference><Citation>Velosa, J. et al. Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. Acta Psychiatr. Scand.141, 510–521 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31954065</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z. et al. Validation of UK biobank data for mental health outcomes: a pilot study using secondary care electronic health records. Int. J. Med. Inform.160, 104704 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8889024</ArticleId><ArticleId IdType="pubmed">35168089</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, D. J. et al. Prevalence and characteristics of probable major depression and bipolar disorder within UK biobank: cross-sectional study of 172,751 participants. PLoS ONE8, 1–7 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839907</ArticleId><ArticleId IdType="pubmed">24282498</ArticleId></ArticleIdList></Reference><Reference><Citation>Tournier, M., Pambrun, E., Maumus-Robert, S., Pariente, A. &amp; Verdoux, H. The risk of dementia in patients using psychotropic drugs: antidepressants, mood stabilizers or antipsychotics. Acta Psychiatr. Scand.145, 56–66 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34689322</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>